|
PCCB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.80880000369521E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.58520000015372E-07 |
| Normal-vs-Stage2 |
3.156700E-03 |
| Normal-vs-Stage3 |
5.24089999953681E-07 |
| Normal-vs-Stage4 |
1.94600000003042E-07 |
| Stage1-vs-Stage2 |
8.966600E-01 |
| Stage1-vs-Stage3 |
4.179600E-01 |
| Stage1-vs-Stage4 |
7.323800E-02 |
| Stage2-vs-Stage3 |
4.558400E-01 |
| Stage2-vs-Stage4 |
9.602100E-02 |
| Stage3-vs-Stage4 |
1.291570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.63360000368951E-08 |
| Normal-vs-AfricanAmerican |
4.08190000023012E-07 |
| Normal-vs-Asian |
1.198180E-02 |
| Caucasian-vs-AfricanAmerican |
5.188800E-01 |
| Caucasian-vs-Asian |
9.860400E-01 |
| AfricanAmerican-vs-Asian |
8.329400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17069999752795E-08 |
| Normal-vs-Female |
7.64050000000571E-05 |
| Male-vs-Female |
1.693400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.75269999999461E-05 |
| Normal-vs-Extreme_Weight |
4.43059999799544E-09 |
| Normal-vs-Obese |
2.65130000176583E-08 |
| Normal-vs-Extreme_Obese |
2.545800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.167800E-01 |
| Normal_Weight-vs-Obese |
3.945800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.478400E-01 |
| Extreme_Weight-vs-Obese |
7.734600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.686600E-01 |
| Obese-vs-Extreme_Obese |
2.369800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.53960000004449E-06 |
| Normal-vs-Age(41-60Yrs) |
6.99430002804036E-09 |
| Normal-vs-Age(61-80Yrs) |
7.52619999988546E-07 |
| Normal-vs-Age(81-100Yrs) |
2.340100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.337400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.446020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.776800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.630400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.070200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.550800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.54460000240309E-08 |
| Normal-VS-Type2 PRCC |
1.802140E-03 |
| Normal-VS-KIRP CIMP |
4.14546175164787E-12 |
| Normal-VS-Unclassified PRCC |
3.5819000000048E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.378310E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.50869999999892E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.878400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.76580000410942E-08 |
| Type2 PRCC-VS-Unclassified PRCC |
1.346360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.752400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3544000005149E-07 |
| Normal-vs-N1 |
7.3310999493259E-09 |
| Normal-vs-N2 |
1.770900E-04 |
| N0-vs-N1 |
3.266400E-01 |
| N0-vs-N2 |
3.125400E-01 |
| N1-vs-N2 |
4.607800E-01 |
|
|
